Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$54.7K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Jun 12 | SER | Serina Therapeutics, Inc. | PBUY | 5,000 | $1.77 | $8.9K | +98.0% | Open the original filing on SEC.gov |
| Jun 11 | SER | Serina Therapeutics, Inc. | PBUY | 5,100 | $1.75 | $8.9K | — | Open the original filing on SEC.gov |
| May 22 | SER | Serina Therapeutics, Inc. | PBUY | 10,000 | $1.93 | $19.3K | +100.0% | Open the original filing on SEC.gov |
| May 21 | SER | Serina Therapeutics, Inc. | PBUY | 10,000 | $1.77 | $17.7K | — | Open the original filing on SEC.gov |
| Nov 13, 2025 | LVTX | LAVA Therapeutics NV | DTOISS◆ | 33,390 | — | — | — | Open the original filing on SEC.gov |
| Nov 13, 2025 | LVTX | LAVA Therapeutics NV | DTOISS | 10,000 | — | — | -100.0% | Open the original filing on SEC.gov |
| Nov 7, 2025 | SER | Serina Therapeutics, Inc. | AGRANT◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| May 19, 2025 | ELTX | Elicio Therapeutics, Inc. | AGRANT◆ | 7,900 | — | — | — | Open the original filing on SEC.gov |